Mazabraud Yann 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Apr 10, 2025
Insider Transaction Report
Form 4
Mazabraud Yann
EVP, Head of International
Transactions
- Sale
Common Stock
2025-04-08$61.54/sh−9,312$573,062→ 22,620 total - Sale
Common Stock
2025-04-08$60.37/sh−8,438$509,435→ 31,932 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024.
- [F2]The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $60.00 to $60.91 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $61.04 to $62.00 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.